1. Home
  2. ACNB vs PRLD Comparison

ACNB vs PRLD Comparison

Compare ACNB & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ACNB Corporation

ACNB

ACNB Corporation

N/A

Current Price

$62.89

Market Cap

659.3M

Sector

Finance

ML Signal

N/A

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

N/A

Current Price

$3.79

Market Cap

529.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ACNB
PRLD
Founded
1857
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
659.3M
529.1M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
ACNB
PRLD
Price
$62.89
$3.79
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
★ $67.67
$9.20
AVG Volume (30 Days)
43.8K
★ 395.6K
Earning Date
10-22-2026
11-11-2026
Dividend Yield
★ 2.70%
N/A
EPS Growth
N/A
★ 23.21
EPS
★ 2.81
N/A
Revenue
★ $191,821,000.00
$12,140,000.00
Revenue This Year
$11.18
$258.83
Revenue Next Year
$2.91
N/A
P/E Ratio
$22.35
★ N/A
Revenue Growth
45.10
★ 73.43
52 Week Low
$42.60
$1.15
52 Week High
$67.60
$6.83

Technical Indicators

Market Signals
Indicator
ACNB
PRLD
Relative Strength Index (RSI) 38.16 32.49
Support Level $51.44 $3.40
Resistance Level $65.62 $4.10
Average True Range (ATR) 1.29 0.28
MACD -0.29 -0.08
Stochastic Oscillator 12.78 11.76

Price Performance

Historical Comparison
ACNB
PRLD

About ACNB ACNB Corporation

ACNB Corp is the financial holding company. Through its wholly-owned subsidiaries, it provides a full range of retail and commercial financial services in Pennsylvania and Maryland through its network of community banking offices. It also provides property, casualty, health, life and disability insurance serving personal and commercial clients through offices in Westminster, Maryland, and Gettysburg, Pennsylvania and is licensed to do business. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage; and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.

Share on Social Networks: